Utilization of chemokine receptors, orphan receptors, and herpesvirus-encoded receptors by diverse human and simian immunodeficiency viruses.
about
In vitro correlates of HIV-2-mediated HIV-1 protectionViral entry through CXCR4 is a pathogenic factor and therapeutic target in human immunodeficiency virus type 1 diseaseCCR8 on human thymocytes functions as a human immunodeficiency virus type 1 coreceptor.An orphan G protein-coupled receptor, GPR1, acts as a coreceptor to allow replication of human immunodeficiency virus types 1 and 2 in brain-derived cellsCCR5, GPR15, and CXCR6 are major coreceptors of human immunodeficiency virus type 2 variants isolated from individuals with and without plasma viremiaHIV type I envelope determinants for use of the CCR2b, CCR3, STRL33, and APJ coreceptorsA novel CCR5 mutation common in sooty mangabeys reveals SIVsmm infection of CCR5-null natural hosts and efficient alternative coreceptor use in vivoDiverse CD81 Proteins Support Hepatitis C Virus InfectionBioinformatic analysis of HIV-1 entry and pathogenesis.Inhibitory mechanism of the CXCR4 antagonist T22 against human immunodeficiency virus type 1 infection.Apelin, a potent diuretic neuropeptide counteracting vasopressin actions through inhibition of vasopressin neuron activity and vasopressin releasePathogenesis of primary R5 human immunodeficiency virus type 1 clones in SCID-hu miceTrafficking to the plasma membrane of the seven-transmembrane protein encoded by human herpesvirus 6 U51 gene involves a cell-specific function present in T lymphocytes.Will multiple coreceptors need to be targeted by inhibitors of human immunodeficiency virus type 1 entry?Functional dissection of CCR5 coreceptor function through the use of CD4-independent simian immunodeficiency virus strainsImmunization with a live, attenuated simian immunodeficiency virus vaccine leads to restriction of viral diversity in Rhesus macaques not protected from pathogenic challenge.V3 recombinants indicate a central role for CCR5 as a coreceptor in tissue infection by human immunodeficiency virus type 1.CXCR-4 is expressed by primary macrophages and supports CCR5-independent infection by dual-tropic but not T-tropic isolates of human immunodeficiency virus type 1Identification of determinants on a dualtropic human immunodeficiency virus type 1 envelope glycoprotein that confer usage of CXCR4Chemokine receptor utilization by human immunodeficiency virus type 1 isolates that replicate in microglia.Determinants of entry cofactor utilization and tropism in a dualtropic human immunodeficiency virus type 1 primary isolate.Patterns of CCR5, CXCR4, and CCR3 usage by envelope glycoproteins from human immunodeficiency virus type 1 primary isolates.The cytomegalovirus-encoded chemokine receptor US28 can enhance cell-cell fusion mediated by different viral proteinsInfluence of the CCR2-V64I polymorphism on human immunodeficiency virus type 1 coreceptor activity and on chemokine receptor function of CCR2b, CCR3, CCR5, and CXCR4.Tat protein induces human immunodeficiency virus type 1 (HIV-1) coreceptors and promotes infection with both macrophage-tropic and T-lymphotropic HIV-1 strains.Chemokine coreceptor usage by diverse primary isolates of human immunodeficiency virus type 1Use of coreceptors other than CCR5 by non-syncytium-inducing adult and pediatric isolates of human immunodeficiency virus type 1 is rare in vitroThe orphan seven-transmembrane receptor apj supports the entry of primary T-cell-line-tropic and dualtropic human immunodeficiency virus type 1.Differential tropism and replication kinetics of human immunodeficiency virus type 1 isolates in thymocytes: coreceptor expression allows viral entry, but productive infection of distinct subsets is determined at the postentry level.Simian immunodeficiency virus utilizes human and sooty mangabey but not rhesus macaque STRL33 for efficient entry.Coreceptor-dependent inhibition of the cell fusion activity of simian immunodeficiency virus Env proteins.Use of inhibitors to evaluate coreceptor usage by simian and simian/human immunodeficiency viruses and human immunodeficiency virus type 2 in primary cells.Expression and use of human immunodeficiency virus type 1 coreceptors by human alveolar macrophagesPatterns of chemokine receptor fusion cofactor utilization by human immunodeficiency virus type 1 variants from the lungs and blood.Analysis of the critical domain in the V3 loop of human immunodeficiency virus type 1 gp120 involved in CCR5 utilization.Determinants of CD4 independence for a human immunodeficiency virus type 1 variant map outside regions required for coreceptor specificity.The level of CD4 expression limits infection of primary rhesus monkey macrophages by a T-tropic simian immunodeficiency virus and macrophagetropic human immunodeficiency viruses.Binding of recombinant feline immunodeficiency virus surface glycoprotein to feline cells: role of CXCR4, cell-surface heparans, and an unidentified non-CXCR4 receptor.Antigenic variation within the CD4 binding site of human immunodeficiency virus type 1 gp120: effects on chemokine receptor utilization.Macrophage tropism of human immunodeficiency virus type 1 isolates from brain and lymphoid tissues predicts neurotropism independent of coreceptor specificity.
P2860
Q22254217-A39C86C6-072F-498B-8C4E-5EE7DB9B3642Q24524292-A9800DD2-3A58-46B8-B45A-F3B1BA7B890CQ24525316-498F7D93-656E-4936-8894-C8E9DCF1DC56Q24527250-0BE93E5C-B338-4D6E-8A1E-A9DC5D90A7C4Q24557545-F6E82DB4-7E5B-41C3-B032-7F75D02618EBQ24682714-A58753D2-75A5-482C-B9C0-6FFB6370CE30Q27313759-C3299570-5EBA-42D1-823A-9B893D1BF5BAQ27477625-E08B1B16-409F-4D08-AE70-4D3F9CF71A11Q27693321-E1978209-88AC-48F3-9489-22655B9E6C13Q28343496-B783EEB1-B4C9-4515-A4A1-882F7E7C499AQ28569332-5E49FF82-49BB-40FF-A52C-0546DFA0A9C0Q30305455-15B5904A-01D6-47B6-B318-05F2D587176CQ33639283-E0A1E29A-2863-4343-9E61-720777143B12Q33645423-A889953E-DB95-47F9-A47A-CF9424645F62Q33647409-DE22B66D-5E97-4134-A235-22E6BE67427CQ33648433-F6A7D19E-474D-4051-8618-39D7D2CA8E15Q33653627-FAD03BA1-5102-4286-BF26-618018A7B96EQ33782165-F2B2F37A-57C6-4638-B620-16D5CB8FB368Q33782530-902254BF-22C8-4266-8C81-3C6E39CD0212Q33782833-3542505A-27EF-4972-B1F3-E574BD298245Q33782925-ABDAC89A-502A-4A7F-85B4-979F32AA8CC9Q33782930-54778B6E-1473-4AD1-9715-99AED930D5A6Q33783347-A2224092-4774-4546-8B3E-5F72A8FA2BD9Q33783914-186D2371-B457-451A-8DE8-E34A0B6D90F8Q33785321-F21187A5-DCA5-4226-866C-729D58EF47E8Q33785473-A334A65C-2BA0-4311-A951-17F0C7602718Q33785490-C94B589B-CE07-4CD2-99D1-A7C8772B906FQ33785770-BEF69C61-E6C7-403A-913F-7BD5BF3AD298Q33785876-6B0C1AAE-A04A-4F6D-9CAE-F16F903843E6Q33787066-5F55A86D-3159-43A0-B06E-FA9CCADF0F8CQ33807244-767AC6C2-B9FC-4585-993F-6F8F509611CBQ33808728-D1EBE4F8-75B2-451F-9202-E50C645A26D1Q33815704-E65A71F9-C1B0-41D5-A2CE-40BED9F38099Q33817409-4A047691-6D5C-489A-BBD6-109919592322Q33819515-B007A3F5-D191-45CC-B606-CCE5843301BAQ33825418-ADDDF522-25F5-4BB6-B5B8-BE1647DDE933Q33826504-E580C43C-AC0B-4E84-951B-89DB0298C762Q33840312-4DA20871-2AEE-4D3F-837C-2D4856965A67Q33841969-98101D59-E667-49D3-A1BF-707BB7C9C00CQ33847458-41127572-6631-4276-9ADD-45F2D70E4775
P2860
Utilization of chemokine receptors, orphan receptors, and herpesvirus-encoded receptors by diverse human and simian immunodeficiency viruses.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Utilization of chemokine recep ...... mian immunodeficiency viruses.
@en
Utilization of chemokine recep ...... mian immunodeficiency viruses.
@nl
type
label
Utilization of chemokine recep ...... mian immunodeficiency viruses.
@en
Utilization of chemokine recep ...... mian immunodeficiency viruses.
@nl
prefLabel
Utilization of chemokine recep ...... mian immunodeficiency viruses.
@en
Utilization of chemokine recep ...... mian immunodeficiency viruses.
@nl
P2093
P2860
P1433
P1476
Utilization of chemokine recep ...... mian immunodeficiency viruses.
@en
P2093
A L Edinger
B J Doranz
B Margulies
J F Berson
M Parmentier
R G Collman
P2860
P304
P407
P577
1997-12-01T00:00:00Z